Ameresco (AMRC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for June 4, 2025, with virtual attendance available for shareholders.
Shareholders are encouraged to review proxy materials and annual report before voting.
Voting matters and shareholder proposals
Election of two directors, Jennifer Miller and Nickolas Stavropoulos, for three-year terms recommended for approval.
Ratification of RSM US LLP as independent registered public accounting firm for fiscal year ending December 31, 2025.
Approval sought for an amendment to the restated certificate of incorporation to limit certain officer liabilities as allowed by Delaware law.
Proxies may vote on other business that arises during the meeting.
Board of directors and corporate governance
Board recommends the election of two directors for new terms.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Ameresco
- Strong earnings growth, robust backlog, and major CO₂ reductions drive sustainable value.AMRC
Investor presentation16 Mar 2026 - Record 2025 results and strong 2026 outlook with revenue guidance up to $2.2B.AMRC
Q4 20252 Mar 2026 - Q2 revenue up 34% to $438M, backlog at $4.4B, and 2024 guidance raised despite margin pressures.AMRC
Q2 20242 Feb 2026 - Managed charging, flexible infrastructure, and new RNG plant drive cost savings and emissions cuts.AMRC
Status Update19 Jan 2026 - Q3 2024 revenue up 49% to $500.9M, record EBITDA, and $4.5B backlog; guidance reaffirmed.AMRC
Q3 202415 Jan 2026 - Q1 2025 revenue and EBITDA surged, backlog hit $4.9B, and 2025 guidance was reaffirmed.AMRC
Q1 202527 Dec 2025 - Virtual meeting to elect directors, ratify auditor, and amend charter for officer exculpation.AMRC
Proxy Filing1 Dec 2025 - Virtual meeting to elect directors, ratify auditor, and amend charter for officer exculpation.AMRC
Proxy Filing1 Dec 2025 - FY24 revenue rose 29% to $1.8B; FY25 guidance: $1.85–$1.95B revenue, $225–$245M EBITDA.AMRC
Q4 20241 Dec 2025